Skip to content
November 04, 2024

Investment information for the new generation

Search

Xphyto Therapeutics (XPHY.C) CEO Hugh Rogers lays out Xphyto’s diversified potential (Ep 5)

Hugh Rogers, Xphyto Therapeutics (XPHY.C) CEO and director, explains the company’s innovative three-pronged business plan involving diagnostics and drug delivery as well as the company’s potential and longevity in a post covid world. Tune in!

Related Posts

More on